Laura Shawver views the field of oncology from the perspective of scientist, drug developer and survivor. Following her own diagnosis and treatment for ovarian cancer in 2007, Dr. Shawver founded The Clearity Foundation to help women with ovarian cancer make more informed treatment decisions. Currently, she is president, chief executive officer, and director of Synthorx, Inc. Prior to joining Synthorx, Dr. Shawver held the following positions: CEO and director of Cleave Biosciences, entrepreneur-in-residence for 5AM Ventures, CEO and director of Phenomix Corporation, and president of SUGEN Inc. (acquired by Pharmacia). Dr. Shawver has been involved with a number of clinical development programs including two FDA-approved therapies. Dr. Shawver is currently a director of Relay Therapeutics as well as an advisor to the industry. She is an active member of the American Association for Cancer Research serving on the Scientific Advisory Committee for Stand Up to Cancer. Dr. Shawver received her Ph.D. in pharmacology and a B.S. degree in microbiology both from the University of Iowa.
Sabrina Martucci Johnson is a life sciences executive with a record of achievement in capital formation, business development, and commercial leadership. Sabrina’s unique background spans finance, global marketing, product development and bench research. Sabrina is committed to advancing innovations in women’s health. In 2015 she founded DARÉ Bioscience to bring novel technologies that clearly address unmet needs to the clinic so that the latest concepts in women’s health make it to market. Prior to founding DARÉ Bioscience, Sabrina was President of WomanCare Global Trading where she responsible for expanding the global product portfolio in women’s health. Formerly, Sabrina was Chief Operating Officer and Chief Financial Officer at Cypress Bioscience, Inc. and held marketing and sales positions with Advanced Tissue Sciences, and a research position with Baxter Healthcare.
Karin’s passion is working with the innovators and change makers of today and tomorrow. As President and Founder of Evoking Insights LLC, Karin operates at the intersection of strategy and leadership as an executive-level coach and strategic advisor. She is known for her ability to make the complex simple and to drive strategic clarity and execution throughout organizations. Karin spent 15 years in various senior leadership positions in the life sciences industry, after transitioning from a decade long consulting career at PricewaterhouseCoopers, LLP. As Vice President Customer Experience for Life Technologies, Karin developed and implemented an enterprise-wide strategy to improve customer experience across all channels and touch-points. As VP of Corporate Strategy at Life Technologies, she partnered with the CEO and executive team to set the strategic direction and plan for the $4B company. Karin has held Board positions with the Healthcare Business Women’s Association and Girls Inc, San Diego. An insatiable learner and adventurer, Karin is constantly challenging herself, and others, to see the world and people in new ways.
Dr. Pamila Brar is Chief Medical Officer and Clinical Phenotyping Research Lead at The J. Craig Venter Institute. In this capacity, she oversees the clinical aspects of a novel research effort that combines the power of genomics (and other molecular tests) with electronic medical records and artificial intelligence to identify markers of health and disease. From 2015 to 2018, Dr. Brar served as Medical Director of the Health Nucleus at Human Longevity, Inc, a precision medicine research clinic. In that role, Dr. Brar led a multidisciplinary team responsible for the integration of whole genome sequencing, microbiome, metabolome and whole-body imaging, as well as the delivery of results to the participants. Pam holds an MD degree from Louisiana State University at New Orleans. She is certified both by the American Board of Internal Medicine, and the American Board of Integrative Holistic Medicine. Dr. Brar is a graduate of the Scripps Clinic Internal Medicine Residency Program and was named the Ellen Browning Scripps Chief Medical Resident in 1998. She then joined the Division of Internal Medicine at Scripps Clinic where she practiced from 1999 to 2009. Pam then opened her own private concierge medicine practice in 2009 in La Jolla, CA. She served as President for the American Academy of Private Physicians from 2015 to 2017. Founded in 2003, the AAPP is a national non-profit organization that provides advocacy for the direct patient-doctor relationship and explores solutions to our changing health care system. Ultimately it was her love for science and innovation that led her to pivot from clinical practice to a precision-medicine based clinical research.
Catherine Cinquegrani is a seasoned and strategic front-line fundraiser with more than fifteen years of fundraising experience. Her expertise spans the fundraising gamut, from annual and special giving, to special events, to major and principal gifts, as well as extensive pipeline development work. She began her career at Scripps Health Foundation in 2001, as a development coordinator, working her way to the role of a Senior Director of Development overseeing the operational aspects of the Foundation. Her current responsibilities include major and principal gift fundraising for Scripps Memorial Hospital, La Jolla and Scripps Clinic. Catherine has an M.A. in Business Administration from San Diego State University and a B.A. in Marketing from Western Michigan University.
Lynnette is a seasoned financial executive with more than 20 years of experience encompassing life sciences, technology and retail. As a Chief Financial Officer she has been responsible for accounting, corporate finance, treasury, purchasing, information technology, human resources and risk management for both public and private companies. She has been successful in raising and restructuring capital for both public and private companies resulting in significant valuation increases. She has held key financial positions for both large public corporations including Blockbuster and Chart House Enterprises as well as medium to smaller venture capital or investment-backed companies, such as Wireless Knowledge, Inc. (a QUALCOMM and Microsoft joint venture), and Catalina Restaurant Group, Inc. Lynnette holds a BBA in Accounting from Baylor University, and is CPA, licensed in the state of California. She also serves as a Board Member for Day for Change, San Diego.
Buck Dodson is a licensed psychotherapist and board certified coach based in Austin, TX. The former president & executive director of Susan Poorman Blackie Ovarian Cancer Foundation and the son of the organization’s late namesake, Buck has been deeply committed to serving women with ovarian cancer and their loved ones since 2012. A longtime supporter of The Clearity Foundation and grateful recipient of the treatment decision making support provided to his family, Buck has worked alongside Clearity leadership since 2016 to integrate psychosocial support through the signature Steps Through OC program. He is honored to join Clearity’s board of directors and eager to participate in leading the organization into its next chapter of providing whole person, personalized cancer care. Along with his personal passion and determination to radically improve the ovarian cancer experience, Buck brings more than two decades of knowledge and professional experience in psychology, social work, philanthropy, and nonprofit leadership to his role as well as the experience of both volunteer and staff at nonprofits in Houston, Los Angeles and Chicago. Buck holds a Master of Social Work from the University of Southern California as well as degrees in Psychology and Nonprofit Management.
Sue is the founder of Ebner Consults which provides sales training and leadership and development training. Sue’s sales training pedagogy is based on the mindful integration of extensive preparation, and the integration of the four Behavior styles throughout the five stages of the sales process. Results are invigorating the sales culture, and accelerating and increasing the sales results of the sales team and organization. Her leadership and development trainings focus on essential leadership skills that enhance the effectiveness of empowering leaders. Prior to launching Ebner Consults, Sue held Sales Executive, Business Development and Account Relationship Manager positions with Mercer, a global consulting leader in talent, health, retirement and investments and a division of MMC, a global $13B, publicly-traded professional services company. Sue has a MBA and a B.S. in International Relations from the University of San Diego. She is currently the CFO of the Athena Foundation, and a member of the University of San Diego, School of Leadership and Education Sciences Advisory Board. She has served as a Board member for Athena, Planned Parenthood Pacific Southwest affiliate, The Old Globe Theatre, American Heart Association and the Senior Community Center.
Kerry Kelly has more than 25 years as an attorney both in private practice and in the biotechnology industry. She currently serves as a consultant to a number of biotech companies. Ms. Kelly was most recently Vice President and General Counsel at Ambit Biosciences, a privately-held biopharmaceutical company engaged in the discovery and development of small-molecule kinase inhibitors for the treatment of cancer. She came to Ambit from The Scripps Research Institute, one of the country’s largest non-profit research organizations where she served as Associate General Counsel. Prior to joining Scripps, Ms. Kelly served as the head of Corporate and Legal Affairs for the biotechnology company SUGEN which developed Sutent™ for renal cell carcinoma and gastrointestinal stromal tumors. (SUGEN was later acquired by Pfizer.) Prior to SUGEN, Ms. Kelly was a partner in the Palo Alto law firm of Bialson, Bergen and Schwab. She received her J.D. from Santa Clara University and her B.A and M.A. from Stanford University.
Jessica McCarthy brings more than 25 years of experience building effective marketing teams and executing successful, high-growth marketing strategies. She has global experience in business-to-business and consumer healthcare marketing, as well as expertise in brand and product marketing, commercial product launches, public relations, product management and health economics. She joined Singulex in 2016, and is responsible for the company’s brand, worldwide product and service launches, health economics and all advertising and promotion. Prior to Singulex, Jessica held leadership roles of increasing responsibility at Blue Shield of California and was most recently Vice President of Integrated Marketing and Customer Experience. Before that, she was a marketing lead at Silicon Valley Bank and managed Fortune 500 and start-up accounts at several global advertising agencies. Jessica earned a B.A. in Religion and Art History from Syracuse University and completed the Women’s Senior Leadership Program at Northwestern University’s Kellogg School of Management. In 2014, The San Francisco Business Times named her one of the “Most Influential Women in the Bay Area,” and inducted her into the “Most Influential Women in the Bay Area Hall of Fame” in 2015.
Michael has more than 30 years of healthcare experience and currently serves as President and CEO of Biocept, an innovative San Diego based molecular diagnostics company developing cutting edge technologies known as liquid biopsies. Prior to Biocept, Mike helped build Clarient from a start up to one of the largest oncology focused diagnostic companies. While at Clarient, Mike worked with our team at Clearity as one of our first diagnostic testing services providers. Prior to joining Clarient, Mr. Nall served in the diagnostic and medical device industries in various leadership roles for companies including Impath, American Cyanamid, Maquet Surgical, Strato Medical, Horizon Medical Products and Columbia Vital Systems. Mr. Nall received a Bachelor of Science degree in Business Administration from Central Missouri State University (now known as the University of Central Missouri) and lives here in Southern California with his wife, Janette.
Michael Pollock currently serves as the President of Reynolds Pollock & Associates, a health outcomes research and market access strategy consulting company. Immediately prior to founding Reynolds Pollock & Associates, Mr. Pollock was vice president of Global Health Economics at Biogen Idec, with worldwide responsibility for health economics strategy and research, across the entire portfolio of marketed and pipeline products. He began his career in Ireland and first became responsible for health economics 20 years ago at Glaxo Canada, where he was instrumental in founding the Pharmaceutical Manufacturers Association of Canada’s Healthcare Economics Committee.
Robin Toft is the President and CEO of Toft Group Executive Search. Prior to establishing the Toft Group in 2010, Robin served as Managing Director of Sanford Rose Associates® – San Francisco since joining the company in 2006. Over her 10+ years in the executive search industry, Robin has placed over 500 executives from Director through C-level, including numerous CEO’s, within rapidly growing biotech, pharmaceutical, diagnostic, medical device, and digital health companies. Robin’s passion is working with private equity, venture-backed, and entrepreneurial early and mid-stage companies to build their management teams. Robin has served on the Board of Directors of the Sidney Kimmel Cancer Foundation of San Diego, CA, was Vice President of the Sanford Rose Associates® Owners Association Board of Trustees, and served as a Director at Innovative Biosensors, Inc., an emerging biotech company based in Rockville, MD. She currently serves on the Board the Scripps Mercy Hospital Foundation Board, and the American Heart Association’s Go Red for Women Executive Leadership Team, and LEAD San Diego, the only organization in the San Diego/Northern Baja California region solely dedicated to developing civically engaged leaders.